0945.HK stock Manulife HKSE HK$291.20 pre-market Feb 07 2026: Feb 11 earnings key
0945.HK stock trades at HK$291.20 pre-market on the Hong Kong Stock Exchange as investors eye Manulife Financial Corporation’s upcoming earnings on 11 Feb 2026. The share is down -0.34% today after opening at HK$291.60, with volume at 11,945 shares versus an average of 13,407. Analysts will watch EPS, capital management and Asia margin trends. This earnings spotlight explains valuation, technical signals, Meyka AI grade and short-term forecasts ahead of the Feb 11 report.
0945.HK stock: Pre-market snapshot and earnings timing
Manulife Financial Corporation (0945.HK) is quoted at HK$291.20 in pre-market trade on the HKSE in Hong Kong. The one-day change is -HK$1.00 or -0.34%, with a day range of HK$289.40–HK$295.80 and a year range of HK$203.20–HK$300.80. Key headline metrics are EPS HK$17.88 and PE 16.29, market cap around HK$501.08B, and shares outstanding 1,720,746,772.00. The company lists its earnings announcement for 2026-02-11, which is the main near-term catalyst for trading activity.
Earnings preview and what to watch in the 0945.HK stock report
Manulife reported fiscal growth trends into 2024 with revenue growth 7.74% and net income growth 3.08% year-over-year. Investors should watch Asia insurance margins, fee income from wealth and asset management, and capital release commentary. Management guidance on reserve assumptions and FX exposure may move the stock ahead of the Feb 11 release. Expect commentary on dividend policy, where trailing dividend per share is HK$1.90 and payout ratio is 55.22%.
Valuation and sector comparison for 0945.HK stock
Manulife trades at a PE 16.29, above the Hong Kong Financial Services sector average PE 13.96. Price-to-book is 1.69, supported by book value per share HK$31.24 and return on equity 11.54%. The stock yields roughly 3.71% trailing. Key balance metrics show debt-to-equity 0.26 and net-debt to EBITDA negative, indicating net cash strength. Relative to peers, 0945.HK carries a modest premium on valuation for its diversified global footprint.
Technical picture and trading signals for 0945.HK stock
Momentum indicators show strength but short-term overbought signals. RSI is 66.41 and ADX is 34.42, indicating a strong trend. Money flow is elevated with MFI 84.47 and CCI 154.68, suggesting short-term fatigue. Price sits slightly above the 50-day average HK$283.76 and above the 200-day average HK$254.94, supporting a constructive medium-term technical bias. Average daily volume 11,945.00 is slightly below the 50-day average of 13,407.00, so intra-day moves can be amplified.
Meyka Grade and Forecast for 0945.HK stock
Meyka AI rates 0945.HK with a score of 76.51 out of 100. Grade: B+ (BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly HK$301.71, quarterly HK$258.59, and yearly HK$274.90. Against the current price HK$291.20, the model implies a monthly upside of 3.61% to HK$301.71. Forecasts are model-based projections and not guarantees.
Price targets and risks for 0945.HK stock
Realistic near-term price targets: base HK$310.00 (implied +6.46%), bear HK$275.00 (implied -5.56%), and bull HK$340.00 (implied +16.75%). Key risks include faster-than-expected interest rate moves, adverse actuarial reserve changes, weaker Asia premium growth, and currency swings. Liquidity and event risk around the Feb 11 earnings can create sharp intraday moves. Review technical stops and position size when trading into the report.
Final Thoughts
0945.HK stock is trading at HK$291.20 pre-market on Feb 07 2026 with an earnings report due on Feb 11 that should set direction. Valuation sits above the financial services sector on PE 16.29 but is supported by stable ROE 11.54%, dividend yield 3.71%, and net cash metrics. Meyka AI’s forecast model projects a monthly price of HK$301.71, an implied near-term upside of 3.61% from the current price. Meyka AI assigns a B+ (76.51/100) grade reflecting solid fundamentals and a constructive outlook. Investors should focus on Asia margin commentary and capital management in the earnings call. Forecasts are model-based projections and not guarantees. Use this earnings window to reassess targets, risk tolerances and position sizing ahead of Feb 11.
FAQs
When will Manulife (0945.HK stock) report earnings?
Manulife Financial Corporation lists its next earnings announcement for 2026-02-11. Expect management commentary on Asia margins, capital management and dividend policy in that release.
What is Meyka AI’s view on 0945.HK stock ahead of earnings?
Meyka AI rates 0945.HK 76.51/100 (B+, BUY) and projects a monthly price of HK$301.71, implying a 3.61% near-term upside from HK$291.20. The grade reflects valuation, growth and analyst signals.
How does valuation compare for 0945.HK stock?
Manulife trades at PE 16.29, above the Financial Services sector average PE 13.96. Price-to-book is 1.69 and trailing dividend yield is 3.71%, showing a modest premium for diversified earnings.
What short-term technical risks should traders watch in 0945.HK stock?
Short-term indicators show overbought signals: RSI 66.41, MFI 84.47, and CCI 154.68. ADX 34.42 signals a strong trend but volume is slightly below average, which can increase volatility around earnings.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)